Association between self-reported hypertension onset age and electrocardiographic left ventricular hypertrophy.


Journal

Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625

Informations de publication

Date de publication:
05 2021
Historique:
received: 05 07 2020
accepted: 01 10 2020
revised: 01 10 2020
pubmed: 21 10 2020
medline: 22 9 2021
entrez: 20 10 2020
Statut: ppublish

Résumé

Objectively defined early-onset hypertension, based on repeated blood pressure measurements, is associated with greater odds of organ damage and cardiovascular mortality than late-onset hypertension. In this study we examined the association between two factors that are easily available in primary care, self-reported hypertension onset age and electrocardiographic left ventricular hypertrophy (ECG-LVH), in a nationwide population sample of 2864 Finns aged ≥50 years. We observed that, in contrast to prior findings, the odds of ECG-LVH were similar between self-reported hypertension onset age groups, and thus self-reported early-onset hypertension does not seem to associate with ECG-LVH more strongly than simple presence of hypertension.

Identifiants

pubmed: 33077804
doi: 10.1038/s41371-020-00428-w
pii: 10.1038/s41371-020-00428-w
doi:

Types de publication

Letter Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-482

Références

Buck C, Baker P, Bass M, Donner A. The prognosis of hypertension according to age at onset. Hypertension. 1987;9:204–8.
doi: 10.1161/01.HYP.9.2.204
Niiranen TJ, McCabe EL, Larson MG, Henglin M, Lakdawala NK, Vasan RS, et al. Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study. BMJ. 2017;357:j1949.
doi: 10.1136/bmj.j1949
Niiranen TJ, Larson MG, McCabe EL, Xanthakis V, Vasan RS, Cheng S. Prognosis of prehypertension without progression to hypertension. Circulation. 2017;136:1262–4.
doi: 10.1161/CIRCULATIONAHA.117.029317
Suvila K, McCabe EL, Lehtonen A, Ebinger JE, Lima JAC, Cheng S, et al. Early onset hypertension is associated with hypertensive end-organ damage already by midLife. Hypertension. 2019; https://doi.org/10.1161/HYPERTENSIONAHA.119.13069 .
Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol. 2020;75:2921–30.
doi: 10.1016/j.jacc.2020.04.038
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.
doi: 10.1097/HJH.0000000000001940
National Institute for Health and Clinical Excellence. Hypertension in adults: diagnosis and management (NICE guideline 136). 2016; https://www.nice.org.uk/guidance/ng136 . Accessed 20 Aug 2020.
Heistaro S. Methodology Report. The Health 2000 Survey. http://urn.fi/URN:NBN:fi-fe201204193320 ; Helsinki, Finland: National Public Health Institute; 2008.
Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation. 2003;108:684–90.
doi: 10.1161/01.CIR.0000083724.28630.C3
Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815–20.
doi: 10.1161/01.CIR.81.3.815
Suvila K, McCabe EL, Lima JAC, Aittokallio J, Yano Y, Cheng S, et al. Self-reported age of hypertension onset and hypertension-mediated organ damage in middle-aged individuals. Am J Hypertens. 2020; https://doi.org/10.1093/ajh/hpaa055 .
Working group appointed by the Finnish Hypertension Society. Hypertension. Current Care Guideline. Duodecim. 2002;118:110–26.

Auteurs

Arttu O Lehtonen (AO)

Finnish Institute for Health and Welfare, Turku, Finland. arolle@utu.fi.
Department of Geriatrics, University of Turku, Turku, Finland. arolle@utu.fi.

Karri Suvila (K)

Finnish Institute for Health and Welfare, Turku, Finland.
Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Antti M Jula (AM)

Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Teemu J Niiranen (TJ)

Finnish Institute for Health and Welfare, Turku, Finland.
Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH